#United States #Chicago #patient monitoring #Sibel Health #ANNE One

Sibel Health's Revolutionary ANNE® One: A New Era in Patient Monitoring

In a significant leap forward for healthcare technology, Sibel Health Inc. has announced the receipt of CE Mark certification under the European Union Medical Device Regulation (EU MDR 2017/745) for its ANNE® One system, now classified as a Class IIb medical device. This approval not only marks a monumental achievement for Sibel Health but also presents a timely solution to the pressing challenges within the European healthcare landscape.

As the demographic landscape shifts, nearly 22% of the EU’s populace is now aged 65 or older. Concurrently, the European Commission anticipates a critical shortage of around 1.2 million healthcare professionals, encompassing doctors, nurses, and midwives. Facing unprecedented workloads and drawn-out shifts, nurses today grapple with burnout, exacerbating the need for innovative solutions. Enter ANNE® One—a wireless and wearable patient monitoring platform designed to empower healthcare professionals.

Key Features of ANNE® One

The ANNE® One platform signifies the fusion of traditional medical monitoring with cutting-edge technology. It provides continuous, multi-parameter monitoring, including ECG, heart rate, respiratory rate, SpO₂, pulse rate, body temperature, activity levels, and even fall detection. These features are complemented by the ANNE® View bedside application and a centralized dashboard, allowing for multi-patient surveillance. This setup alerts healthcare professionals when patient metrics deviate from predetermined thresholds, offering the crucial ability to intervene at the right moment.

According to Steve Xu, MD, CEO and Co-Founder of Sibel Health, “Our mission has always been to ensure that high-quality continuous monitoring reaches every patient—whether it's expectant mothers in developing nations or postoperative patients in urban centers.” This ethos is even more striking in light of the rigorous processes required for Class IIb certification, which involves extensive scrutiny of design, clinical performance, and quality management systems.

Emphasis on Interoperability

Adding to its accolades, the ANNE® One platform is the pioneer in obtaining certification under the IEEE 11073 Service-Oriented Device Connectivity (SDC) standards. This foundational aspect allows it to communicate seamlessly with other compatible devices and hospital IT systems, free from restrictive gateways or vendor lock-in. Sibel Health has partnered with Dräger, a leader in medical technology, to enhance the deployment of ANNE® One across European hospitals. Dr. Jakob Kleissl, President of BU Patient Monitoring at Drägerwerk AG, remarked, “Sibel's strategy to develop ANNE® One on the SDC standard exemplifies the biochemical and interoperable approach that has become essential in patient monitoring today.”

A Response to Challenging Healthcare Demands

The importance of such innovations cannot be overstated, especially given the current pressing demands faced by healthcare systems. The Capital Region of Denmark has already engaged Sibel and Dräger to implement this technology, showcasing its direct impact on improving nurse capabilities in medical and surgical wards throughout Copenhagen hospitals.

In conclusion, the ANNE® One system not only revolutionizes patient monitoring but also exemplifies a commitment to enhancing healthcare outcomes. With its robust features and interoperability aspects, it stands as a beacon of what the future holds for medical technology.

For more information about Sibel Health and the ANNE® platform, visit Sibel Health's Official Website.